Epidemiology and diagnosis of the pancreatic cancer;Cáncer de páncreas. Epidemiología y diagnó stico

Revista Espanola de Enfermedades Digestivas

Volumn 96, Issue 10, 2004, Pages 714-722

  Hidalgo Pascual, Manuel ^a   Ferrero Herrero, E ^a   Castillo Fe M J ^a   Guadarrama Gonzalez F J ^a   Pelaez Torres P ^a   Botella Ballesteros, F ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 NAPHTHYLAMINE; BENZIDINE; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CA 242 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; MEMBRANE ANTIGEN; NITROSAMINE; PETROLEUM; PYRUVATE KINASE; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ANGIOGRAPHY; ASPIRATION BIOPSY; BLOOD ANALYSIS; CANADA; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER PAIN; CANCER STAGING; CHINESE; CIGARETTE SMOKING; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DEMOGRAPHY; DIABETES MELLITUS; DIETARY INTAKE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EUROPE; FEMALE; FRANCE; GASTROINTESTINAL RADIOGRAPHY; HISPANIC; HUMAN; INHERITANCE; ISRAEL; ITALY; LAPAROSCOPY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; RACE DIFFERENCE; REVIEW; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SPAIN; UNITED STATES;

DIAGNOSIS, DIFFERENTIAL; HUMANS; PANCREATIC NEOPLASMS; RISK FACTORS;

EID: 9744246071     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. De Diego IA. Tumores del páncreas exocrino. En: Balibrea Cantero JL, ed. Tratado de Cirugía. Tomo II. Barcelona: Ediciones Toray S.A., 1989. p. 2578-87.
2. Moossa AR. Tumours of the pancreas. In: Moossa AR, Schimpf SC, Rabson MC. Comprehensive textbook of oncology. Volumen I. Second ed. Williams and Wilkins, 1991. p. 958-88.
3. Mori K, Ikei S, Yamane T, Yamaguchi Y, Katsumori T, Shiabta Y, Arai T. Pathological factors influencing survival of carcinoma of the ampulla of vater. Europ J Surg On 1990; 16; 183-7.
4. Schwartz S. Cirugía de páncreas. En: Schwartz, Shires y Spencer, eds. Principios de Cirugía. Interamericana, 1991.
5. Hoover R, Mason T, Mckay F, et al. Geographic patterns of cancer mortality in the United States. In: Fraumeni JF, ed. Persons at High Risk of Cancer. An Approach to Cancer Etiology and Control. New York: Academic Press, 1975. p. 343-60.
6. Appel MJ, Meijers M, Van Garderen-Hoetner A, Lamers CB, et al. Role of cholecystectokinin in dietary fat-promotedaserine induced pancreatic carcinogenesis in rats. Br J Cancer 1992; 66: 46-50.
7. Mac Mahon B, Yen S, Trichopoulos D, et al. Coffee and cancer of the pancreas. N Engl J Med 1981; 304: 630.
8. Feinsten A, Horowitz R, Spitzer W, et al. Coffee and pancreatic cancer: the problems of etiologic science and epidemiologic case-control research. JAMA 1981; 246: 957.
9. Howe GR, Burch JD. Nutrition and pancreatic cancer. Cancer Causes Control 1996; 7: 69-82.
10. Hakulinen T, Lehtimaki L, Lehtonen M, et al. Cancer morbidity among two male cohorts with increased alcohol consumption in Finland. J Natl Cancer Inst 1974; 52: 1711.
11. Wynder E, Mabuchi K, Maruchi N, et al. A case control study of cancer of the pancreas. Cancer 1973; 31: 641.
12. Wynder E, Mabuchi K, Maruchi N, et al. Epidemiology of cancer of the pancreas. J Natl Cancer Inst 1973; 50: 645.
13. Monson R, Lyon J. Proportional mortality among alcoholics. Cancer 1975; 36: 1077.
14. Newcomb PA, Carbone PP. The health consequences of smoking. Med Clin North 1991; 6: 305-31.
15. Kahn H. The Dorn study of smoking and mortality among US veterans: report on eight and one-half years observation. Natl Cancer Inst Monogr 1966; 19: 1.
16. Sindelar W, Kurman C. Nitrosamine-induced pancreatic carcinogenesis in outbred and inbred Syrian hamsters. Carcinogenesis 1982; 3: 1021.
17. Beger HC, Büchler M, eds. Chronic pancreatitis. Research and clinical management. Springer Verlag, 1990.
18. Brooks J. Cancer of the pancreas. In: Brooks JR, ed. Surgery of the pancreas. Philadelphia: WB Saunders, 1983. p. 263.
19. Sasaki A, Kamado K, Horiuchi N. A changing pattern of causes of death in japanese diabetics. Observations over fifteen years. J Chronic Dis 1978; 312: 433.
20. Ghadirian P, Boyle P, Simard A. Reported family aggregation of pancreatic cancer within population-based-case-control study. Pancreas 1991; 10: 183-96.
21. Fernández E, La Vecchia C, Decarli A. Attributable risk for pancreatic cancer in northern Italy. Cancer Epidemiol. Biomarkers 1996; 5: 23-7.
22. a ed. Nueva York: Oxford University Press, 1996. p. 725-71.
23. Swift M, Morrell D, Massey RB, Chase CL. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 1991; 325: 1831-6.
24. Ozcelik H, Schmocker B, Di Nicola N, Shi XH, Langer B, Moore M, et al. Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat Genet 1997; 16: 17-8.
25. Braganza JM. Pancreatic disease: a casualty of hepatic "detoxification"? Lancet 1983; 29: 1000-3.
26. Collier JD, Bennett MK, Hall A, Cattan AR, Lendrum R, Bassendine MF. Expression of glutathione S-transferases in normal and malignant pancreas: an immunohistochemical study. Gut 1994; 35: 266-9.
27. Mancuso T, El-Attar A. Cohort study of workers exposed to betanaphythylamine and benzidine. J Occup Med 1967; 9: 277.
28. Pour P, Althoff J, Kruger F, et al. The effect of N-Nitrosobis (2-oxopropyl)almine after administration to hamsters. Cancer Lett 1977; 2: 323.
29. Longnecker D, Curphey T. Adenocarcinoma of the pancreas in azaserine-treated rats. Cancer Res 1975; 35: 2249.
30. Duran H. Quistes y pseudoquistes. En: Durán Sacristán H, Arcelus I, García-Sancho L, González F, Álvarez J, Fernández L, Méndez J, eds. Tratado de Patología y Clínica Quirúirgicas. Madrid: Interamericana McGraw-Hill, 1992. p. 2818-53.
31. Cancer of the pancreas Task force: Staging of cancer of the pancreas. Cancer 1981; 47: 1631.
32. Gudjonsson B. Livestone EM. Spiro HM. Cancer of the pancreas. Diagnostic accuracy and survival statistics. Cancer 1978; 42: 2494.
33. Howard JM, Jordan GL. Cancer of the pancreas. Curr Probl Cancer 1977; 2: 1.
34. Go VLW, Taylor WF, DiMagno EP. Efforts and early diagnosis of pancreatic cancer: The Mayo Clinic experience. Cancer 1981; 47: 1698.
35. Fras I, Litin EM, Pearson JS. Comparison of psychiatric symptoms in carcinoma of the pancreas with those in some other intra-abdominal neoplasms. Am J Psychiatry 1967; 123: 1553.
36. Sack GH, Levin J, Bell WR. Trousseau's syndrome and other manifestations of chronic disseminated coagulapathy in patients with neoplasms: clinical, pathophysiologic and therapeutic features. Medicine 1977; 56: 1.
37. Moertel CG. Exocrine pancreas. In: Holland JF, Frei E, eds. Cancer Medicine. 2nd ed. Philadelphia: Lea & Febiger, 1982. p. 1792-804.
38. Bengmark S. Progress in surgery of the liver and biliary system. Martinua Nijhoff Publish, 1988.
39. Moossa AR. Diagnosis and treatment of "early" pancreatic cancer. In: Williams LF, Sawyer JL, eds. Difficult problems in general surgery. Chicago: Year Book Medical Publishers, 1989. p. 285-98.
40. Rösch T, Lorenz R, Braig C, Fenerbach S, Siewert JR, Schusdziarra V, et al. Endoscopic Ultrasound in pancreatic Tumor diagnosis. Gastrointestinal 1991; 37: 347-52.
41. Legman P, Viguanse O, Dourset B, et al. Pancreatic tumors: comparison of dual-phase helical and endoscopic soundography. Anna J Radial 1998; 170: 1315-22.
42. Faisel DO, Ginsbrg GG, Bentz IS, Gupta PK, Smith DB, Kochman ML. Endoscopic ultrasound-gided realtime fine needle aspiration biopsy of the pancreas in cancer patients with pancreatic lesions. J Clin Oncol 1997; 15: 1439-43.
43. Catalano C, Laghi A, Fraioli F, Napoli A, Danti M, Reitano I, et al. Pancreatic carcinoma: the role of high-resolution miltislice spiral CT in the diagnosisis and assessment of respectability. Eur Radiol 2002; 13: 149-56.
44. Yoshida T, Matsumoto T, Morii Y, Ishio T, Kitano S, Yamada Y, et al. Staging with helicol computed tomography and laparoscopy in pancreatic head cancer. Hepatogastroenterology 2002; 49: 1428-31.
45. Zeman RK, Cooper, Zeiberg AS, et al. TNM Stafing of pancreatic carcinoma using hecal CT. AJR J Rosentsenol 1997; 169: 459-64.
46. Diehl SJ, Lehmann KJ, Sadick M, Lachmann R, Georgi M. Pancreatic cancer value of dual-phase helical CT assessing respectability. Radiology 1998; 206: 373-8.
47. Prokech RW, Chow LC, Beaulieu Ch F, Nino-Murcia M, Mindelzun RE, Bamer R, et al. Local staging of pancreatic carcinoma with multidetector row CT: Use of curve planar reformations. Initial experience. Radiology 2002; 225: 759-65.
48. Tanizawa Y, Nakagohri T, Konoshi M, Inoue K, Oda T, Takahashi S, et al. Virtual pancreatoscopy of pancreatic cancer. Hepato-gastroenterology 2003; 50: 559-62.
49. Wilson MB, Adams DB, Garen PD, Gansler TS. Aspiration cytologic, ultrastructural and DNA cytometric findings of solid and papillary tumour of the pancreas. Cancer 1992; 69: 2235-43.
50. Nieveen van Dijkum EJ, Romijn MG, Terwee CB, de Wit LT, van der Meulen JH, Lameris HS, et al. Laparoscopic staging and subsequent palliation in patients with peripancreatic carcinoma. Ann Surg 2003; 237: 66-73.
51. Moosa AR, Levin B. The diagnosis of "early" pancreatic cancer. The University of Chicago experience. Cancer 1981; 47: 1688.
52. Holyoke ED, Evans JT, Mittleman A. Biochemical markers for cancer. New York: Marcel Dekker, 1982. p. 61-80.
53. Van Nagell Jr. Tumour markers in ovarian cancer. Clin Obstet Gynecol 1983; 10: 197.
54. Pentti K, Keinonen KT, Koiwla T, et al. Tumour associated antigen CA 12-5 in patients with ovarian cancer. Br J Obstet Gyneacol 1985; 92: 528.
55. Bast RC, Klug TL, St. John E, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 1983; 309: 883.
56. Steinberg WM, Gelfand R, Anderson KK, et al. Comparison of the sensivity and specificity of the CA 19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas. Gastroenterology 1986; 90: 343.
57. Piantino P, Andriulli A, Gindro T, et al. CA 19-9 assay in differential diagnosis of pancreatic carcinoma from inflammatory pancreatic diseases. Am J Gastroenterol 1986; 81: 436.
58. Haglund C, Roberts PJ, Kuusela P. et al. Gatsroeintestinal cancer associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreattits. Br J Cancer 1986; 53: 189.
59. Pasquali C, Sperti C. D'Andrea AA, et al. Evaluation of carbohydrate antigens 19-9 and 12-5 in patients with pancreatic cancer. Pancreas 1987; 2: 34.
60. Sakahara H, Endo K, Nakajima K, et al. Serum CA 19-9 concentrations and computed tomography findings in patients in patients with pancreatic carcinoma. Cancer 1986; 57: 1324.
61. Tempero M, Uchida E, Takasaki H, et al. Serial CA 19-9 levels and tumour response in pancreatic cancer (abstr.). Proc Am Soc Clin Oncol 1987; 6: 81.
62. Scholm J, Weeks MO. Potential clinical utility of monoclonal antibodies in the management of human carcinomas. In: Devita UT Jr, Rosenberg SA, eds. Important advances in oncology. Philadelphia: J.B. Lippincott, 1985. p. 170.
63. Lindahl AK, Odegaard OR, Sandset PM, et al. Coagulation inhibition and activation in pancreatic cancer. Cancer 1992; 70: 2067-72.
64. Kimura N, Yonekura H, Okamoto MD, et al. Expression of human regenerating gene in RNA and its product in normal and pancreatic human pancreas. Cancer 1992; 70: 1857-63.
65. Parker N, Makin CA, Ching CK, at al. A new enzyme linked lectin/mucin antibody sandwich assay (CAM 17,1/WGA). Cancer 1992; 70: 1062-8.
66. Hosono M, Eudo K. Sakahara H, et al. Human mouse chimeric antobodies show low reactivity with human antimurine antibodies (HAMA). Br J Cancer 1992; 65: 197-200.
67. Van Erp H, Van Vunik J, Rijsen G, et al. Cellular expression of K-type pyruvate kinase in normal and neoplastic human tissues. Cancer 1992; 68: 2595-600.
68. Pasamen PA, Eskelimen M, Pastamen K, et al. Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma. Br J Cancer 1992; 65: 731-4.
69. Kawa S, Kato M, Hsue L, et al. Clinical evaluation of pancreatic cancer associated inucin expressing CA 19-9, CA 50, sialy SSEA-1 an Dupan 2. Scand J Gastroenterol 1992; 27: 635-43.